By the BossCE Editorial Team.
Key Points
- An adult on an anticoagulant who bumps their head, with no other reason to scan, should be considered for a CT head within 8 hours of the injury under NICE. Since 2023 NICE says “consider”, not “do” [1][2].
- NICE now gives the same advice for antiplatelets, except aspirin monotherapy [1]. The Malaysian CPG and ACEP make no such exception for aspirin [3][4].
- Symptoms change the urgency. In Malaysia, an anticoagulated or antiplatelet patient with headache, loss of consciousness, amnesia or vomiting needs an immediate scan [3].
- The Canadian CT Head Rule does not apply to anticoagulated patients [3][4].
- After a normal first CT, delayed bleeding is uncommon and rarely needs surgery. NICE and ACEP do not admit on drug status alone. The 2015 Malaysian CPG still advises ward admission [2][3][4][6].
Why These Patients Are Different
Most minor head injuries can be triaged with a clinical decision rule. Patients on blood thinners are the exception. The Canadian CT Head Rule was not designed for patients on anticoagulants, and the Malaysian CPG states it is not applicable in that group [3]. ACEP advises against using any decision tool to rule out CT in a patient on an anticoagulant or a non-aspirin antiplatelet [4].
The bleed rate is meaningful even when the patient looks well. A 2024 meta-analysis of 28 studies and 11,172 patients with mild traumatic brain injury on oral anticoagulants found intracranial haemorrhage on the first scan in 8.5% [5]. The rate was 6.4% on DOACs and 10.5% on vitamin K antagonists, and DOAC users had lower odds of haemorrhage than warfarin users (OR 0.64) [5]. The Malaysian CPG cites a study in which 29% of patients on anticoagulant or antiplatelet therapy had a positive CT despite a GCS of 15 [3].
Who Needs a Scan, and How Fast
Start with the standard high-risk features. Under NICE, any adult with one of the following needs a CT head within 1 hour [1]:
- GCS 12 or less on initial assessment in the emergency department, or below 15 at 2 hours after the injury.
- Suspected open or depressed skull fracture, or any sign of basal skull fracture.
- Post-traumatic seizure or a focal neurological deficit.
- More than 1 episode of vomiting.
An adult with loss of consciousness or amnesia plus age 65 or over, a bleeding or clotting disorder, a dangerous mechanism or more than 30 minutes of retrograde amnesia needs a CT within 8 hours of the injury [1].
If none of these apply, the drug history decides. NICE recommends considering a CT head within 8 hours of injury for people on vitamin K antagonists, DOACs, heparin or low molecular weight heparin, or on antiplatelets other than aspirin monotherapy. This applies, for example, when risk assessment is difficult or the patient might not come back if they deteriorate. If they present more than 8 hours after the injury, scan within the hour [1].
What Changed in NICE 2023
The 2014 NICE guidance said to scan every anticoagulated patient within 8 hours. In 2023 the committee found conflicting cohort evidence on whether these patients are at higher risk. They judged it too weak to stop scanning altogether, so they changed “offer” to “consider” [2]. They also added antiplatelets other than aspirin monotherapy, which brings in clopidogrel, prasugrel and ticagrelor [2]. NICE expects fewer scans in anticoagulated patients and more in those on these antiplatelets. It is uncertain whether the overall number will rise or fall [2].
In practice, “consider” leaves room for judgement. Scanning remains the safer default in the older, frail, cognitively impaired or poorly supported patient.
Guidance Compared
| Question | NICE NG232 (UK, 2023) [1][2] | MOH Malaysia CPG (2015) [3] | ACEP (US, 2023) [4] |
|---|---|---|---|
| Anticoagulant, no other indication | Consider CT within 8 hours of injury | Urgent CT within 6–8 hours | Do not use decision tools to exclude CT |
| Antiplatelet | As above, except aspirin monotherapy | Any antiplatelet treated as a risk factor | Applies to antiplatelets other than aspirin |
| Symptomatic (headache, LOC, amnesia, vomiting) | Apply the standard 1-hour and 8-hour criteria | Immediate CT, within 1–2 hours of the risk factor being identified | Not specified separately |
| Admit after a normal CT? | Drug status alone is not an indication | Admit to ward irrespective of CT findings | Do not routinely admit or observe |
| Routine repeat CT? | No specific recommendation | Insufficient evidence to recommend routinely | Do not routinely repeat |
The Malaysian CPG predates NICE 2023 and was adapted from the 2014 NICE guidance [3]. It also excludes patients on anticoagulants or antiplatelets from its 6-hour emergency department observation pathway for mild head injury [3].
Delayed Bleeding After a Normal Scan
The fear of a delayed bleed drove routine admission and repeat CT for years. A 2024 meta-analysis of 26 studies and 7,218 anticoagulated patients with a negative first CT found delayed haemorrhage on repeat CT within 24 hours in 2.0% [6]. Only 0.1% needed neurosurgery and 0.1% died [6]. The pooled rate was 27.1 per 1,000 on vitamin K antagonists and 20.5 per 1,000 on DOACs [6]. Risk factors included GCS below 15, loss of consciousness, post-traumatic amnesia and an Abbreviated Injury Scale head score of 3 or more [6]. The other meta-analysis put delayed haemorrhage at 1.7% [5].
On this basis ACEP advises against routine repeat imaging or admission for patients on anticoagulants or antiplatelets who are at their neurological baseline after a CT without haemorrhage [4]. NICE reached a similar view. Large observational data showed no clinically important difference in delayed bleeding with pre-injury anticoagulation, and drug status alone should not trigger admission [2].
The Malaysian CPG is more cautious. It advises admitting patients with mild head injury who are 65 or over, or on anticoagulants or antiplatelets, regardless of CT findings [3]. It finds insufficient evidence for routine repeat CT. It does cite evidence that patients aged 65 or over on low-dose aspirin with a negative first scan should have a repeat CT at 12–24 hours or at least 48 hours of observation [3]. Clinicians in Malaysia should follow local protocol. Expect this to be revisited when the CPG is updated.
Discharge, Admission and Reversal
- Skull fracture: NICE treats an isolated simple linear skull fracture as unlikely to be clinically important, unless the patient is on anticoagulants or antiplatelets [1].
- Supervision: make sure people with pre-injury cognitive impairment are supervised and monitored after discharge [1]. They may not report early signs of a late bleed [2].
- Advice: give written instructions on the symptoms of delayed haemorrhage [4]. ACEP also suggests outpatient referral to assess falls risk and the balance of risk and benefit of anticoagulation [4].
- If there is a bleed: stop and reverse the anticoagulant with input from relevant specialties [3]. NICE points to its transfusion guideline for prothrombin complex concentrate after warfarin and to MHRA advice for DOAC reversal agents [1]. The Malaysian CPG finds insufficient evidence for routine platelet transfusion in mild head injury on antiplatelets [3].
For Primary Care and Dental Teams
A patient on warfarin or apixaban who slips in the surgery car park, or faints in the dental chair and strikes their head, belongs in an emergency department, not at home with a head injury leaflet. NICE names GPs and dental practitioners among the community services that should refer to an emergency department, and anticoagulant or antiplatelet treatment, other than aspirin monotherapy, is one of the referral criteria [1]. The Malaysian CPG lists antiplatelet or anticoagulant treatment among the factors favouring referral to the nearest hospital [3]. Our guides to anticoagulants and antiplatelets before dental extraction and dengue warning signs cover other situations where these drugs change the plan.
Ask BossCE AI
Ask BossCE AI a follow-up question, such as how to manage a patient on dual antiplatelet therapy after a fall with a normal CT, and check each numbered source for yourself.
Sources
- National Institute for Health and Care Excellence. Head Injury: Assessment and Early Management (NG232). Recommendations. Published 18 May 2023. nice.org.uk
- National Institute for Health and Care Excellence. Head Injury: Assessment and Early Management (NG232). Rationale and Impact. 2023. nice.org.uk
- Ministry of Health Malaysia. Clinical Practice Guidelines: Early Management of Head Injury in Adults. MaHTAS; 2015. BossCE Library. moh.gov.my
- American College of Emergency Physicians Clinical Policies Subcommittee. Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Mild Traumatic Brain Injury. Ann Emerg Med. 2023;81(5):e63–e105. pmc.ncbi.nlm.nih.gov
- Karamian A, Seifi A, Karamian A, Lucke-Wold B. Incidence of Intracranial Bleeding in Mild Traumatic Brain Injury Patients Taking Oral Anticoagulants: A Systematic Review and Meta-Analysis. J Neurol. 2024;271(7):3849–3868. doi.org
- Pessôa RL, Garcia GM, Becker GG, et al. Incidence and Risk Factors of Delayed Intracranial Hemorrhage in Anticoagulated Head Trauma Patients: A Systematic Review and Meta-Analysis. World Neurosurg. 2024;192:190–200.e6. doi.org
This article is for qualified healthcare professionals and is not a substitute for clinical judgement or the full guideline. Check the current version of each source before applying it.

